Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
(21)
•••
CoffeeBeans
X
View Profile
View Bullboard History
Post by
CoffeeBeans
on May 16, 2023 8:56am
Grade 12 science class for life
That's all Wallace is doing. Repeating for the last 10+ years science experiments with nothing to show except a well paid job for him and his pilot buddy. In 2017 this was $0.08 (yes 8 pennies), 6
...more
(450)
•••
davgro
X
View Profile
View Bullboard History
Comment by
davgro
on May 15, 2023 3:07pm
RE:More Buying 💀🦴🎲🎲
The Dumpster can't decide whether to pump or bash this stock. It really must eat at him when he buys ATE just to flip it for a few pennies and the stock price continues to fall well below
...more
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on May 15, 2023 2:43pm
OMG
now 49 pennies, no one trusts these guys, or believes in the new formula?
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on May 15, 2023 12:28pm
WOW!👺
looks like they could not scare up any investors at those conferences, back to 51 pennies
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on May 04, 2023 1:02pm
$2.00 Price Target
next news end of june. https://money.tmx.com/en/quote/ATE/analysts
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on May 04, 2023 10:38am
Insider Buying
j stauffer 16,666 a stegic 3,333
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on May 03, 2023 10:39am
ATE
Bid Orders Volume Price 5 4,500 0.54 6
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on May 02, 2023 1:49pm
RE:No effect on the stock price 🤷♂️
Someone bought 84K shares at open without moving the needle...1 cent drop on the scraps after
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on May 02, 2023 1:33pm
No effect on the stock price 🤷♂️
Dr. Joseph Stauffer, Antibe's Chief Medical Officer, will deliver a live presentation discussing Antibe's clinical program for otenaproxesul: Date: Tuesday, May 2, 2023 Time: 12
...more
(26)
•••
Pronorvista
X
View Profile
View Bullboard History
Post by
Pronorvista
on Apr 28, 2023 9:50am
ATE
Bid Orders Volume Price 4 4,000 0.54 7 130,000 0.53 4 22,500 0.52
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 28, 2023 12:26am
RE:RE:Presentation ...
I think the March presentation is carrying all/most of the slides they presented.
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Comment by
Duster340
on Apr 27, 2023 11:18am
RE:Presentation ...
maybe scott was excited because it was a payday friday and a long weekend. but not excited enough to do some insider buying LOL
(1093)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 27, 2023 11:10am
Let Us Hope and pray ⛪🙏
they can scare up a few investors next week. Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical-stage company leveraging its hydrogen sulfide platform to develop next-generation safer
...more
(376)
•••
woundedknee
X
View Profile
View Bullboard History
Comment by
woundedknee
on Apr 27, 2023 9:26am
RE:RE:RE:Sorry Mugsy
Mugsy, I didn't literally want you to sell. It was just an opinion that I believe that this company's products have very little space in the market place. Even if I'm wrong in that
...more
(55)
•••
Harper75
X
View Profile
View Bullboard History
Comment by
Harper75
on Apr 27, 2023 8:42am
RE:Presentation ...
Any chance the presentation is posted online? Struck out on Antibe's site.
Prev
...
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >